Johannessen TA et al. |
Rapid Conversion of Mutant IDH1 from Driver to Passenger in a Model of Human Gliomagenesis. |
2016 |
Mol. Cancer Res. |
pmid:27430238
|
Kingsbury JM et al. |
Cancer-associated isocitrate dehydrogenase mutations induce mitochondrial DNA instability. |
2016 |
Hum. Mol. Genet. |
pmid:27427385
|
Jafari-Khouzani K et al. |
Volumetric relationship between 2-hydroxyglutarate and FLAIR hyperintensity has potential implications for radiotherapy planning of mutant IDH glioma patients. |
2016 |
Neuro-oncology |
pmid:27382115
|
Hirata M et al. |
Mutant IDH is sufficient to initiate enchondromatosis in mice. |
2015 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:25730874
|
Charitou P et al. |
FOXOs support the metabolic requirements of normal and tumor cells by promoting IDH1 expression. |
2015 |
EMBO Rep. |
pmid:25648147
|
Chan SM et al. |
Isocitrate dehydrogenase 1 and 2 mutations induce BCL-2 dependence in acute myeloid leukemia. |
2015 |
Nat. Med. |
pmid:25599133
|
Fan J et al. |
Human phosphoglycerate dehydrogenase produces the oncometabolite D-2-hydroxyglutarate. |
2015 |
ACS Chem. Biol. |
pmid:25406093
|
Reitman ZJ et al. |
Genetic dissection of leukemia-associated IDH1 and IDH2 mutants and D-2-hydroxyglutarate in Drosophila. |
2015 |
Blood |
pmid:25398939
|
Patay Z et al. |
Successive distinct high-grade gliomas in L-2-hydroxyglutaric aciduria. |
2015 |
J. Inherit. Metab. Dis. |
pmid:25338511
|
Wen H et al. |
Metabolomic comparison between cells over-expressing isocitrate dehydrogenase 1 and 2 mutants and the effects of an inhibitor on the metabolism. |
2015 |
J. Neurochem. |
pmid:25251602
|